Abstract:Protein therapeutics is playing an increasingly critical role in treatment of human diseases. However, current vectors are captured by the digestive endo-lysosomal system, which results in an extremely low fraction (<2%) of protein being released in the cytoplasm. This paper reports a drug-delivering-drug platform (HA-PNPplex, 200 nm) for potent intracellular delivery of protein and combined treatment of cancer. Methods: The platform was prepared by loading functional protein on pure drug nanoparticles (PNPs) followed by hyaluronic acid coating and was characterized by dynamic light scattering, transmission electron microscopy, and gel electrophoresis. In vitro, cellular uptake, trafficking, and cytotoxicity were evaluated by flow cytometry and confocal laser microscopy. Protein expression was assayed by western blot. In vivo, blood circulation and biodistribution were studied using a fluorescence imaging system, antitumor efficacy was assessed in a caspase 3-deficient tumor model, and biocompatibility was determined by comparison of hemolytic activity and proinflammatory cytokines and tissue histology. Results: HA-PNPplex delivered the functional protein, caspase 3, to cells via bypassing endo-lysosomes and raised the caspase-3 level 6.5-fold in caspase 3-deficient cells. Promoted tumor accumulation (1.5-fold) and penetration were exhibited, demonstrating a high tumor-targeting ability of HA-PNPplex. HA-PNPplex rendered a 7-fold increase in caspase 3 in tumor and allowed for a 100% tumor growth inhibition and >60% apoptosis, implying significant antitumor activities. Conclusions: This platform gains cellular entry without entrapment in the endo-lysosomes and enables efficient intracellular protein delivery and resultant profound cancer treatment. This platform, with extremely high drug-loading, is a valuable platform for combined cancer therapy with small-molecule drugs and proteins. More importantly, this work offers a robust and safe approach for protein therapeutics and intracellular delivery of other functional peptides, as well as gene-based therapy.

Engineered Histidine-Rich Peptides Enhance Endosomal Escape for Antibody-Targeted Intracellular Delivery of Functional Proteins

Charge-guided Masking of a Membrane-Destabilizing Peptide Enables Efficient Endosomal Escape for Targeted Intracellular Delivery of Proteins

Intracellular Delivery of Native Proteins Facilitated by Cell-Penetrating Poly(disulfide)s.

Inside Cover: Engineered Histidine‐Rich Peptides Enhance Endosomal Escape for Antibody‐Targeted Intracellular Delivery of Functional Proteins (Angew. Chem. Int. Ed. 38/2023)

Engineering Antibody Fusion Proteins for Targeted Intracellular Therapeutic Delivery

Efficient intracellular delivery of proteins by a multifunctional chimaeric peptide in vitro and in vivo

Zwitterionic Peptide Pendant As a Homing Agent to Achieve Lymphatic Targeting Antigen-Specific Immunotherapy of Allergenic Protein

E3MPH16: An efficient endosomolytic peptide for intracellular protein delivery

Cytosolic Protein Delivery for Intracellular Antigen Targeting Using Supercharged Polypeptide Delivery Platform

Tumor Targeting and Microenvironment-Responsive Multifunctional Fusion Protein for Pro-Apoptotic Peptide Delivery

Overcoming Endosomal Escape Barriers in Gene Drug Delivery Using De Novo Designed Ph-Responsive Peptides

Potent Protein Delivery into Mammalian Cells Via a Supercharged Polypeptide.

A Cell-Penetrating Peptide Improves Anti-HER2 Single-Chain Variable Fragment Internalization and Antitumor Activity Against HER2-Positive Breast Cancer in Vitro and in Vivo

A high hydrophobic moment arginine-rich peptide screened by a machine learning algorithm enhanced ADC antitumor activity

Aptamer and Phosphorothioated DNA Engineered Liposomes As a Targeted Intracellular Protein Delivery System

Drug-delivering-drug platform-mediated potent protein therapeutics via a non-endo-lysosomal route.

Endocytosis‐independent and Cancer‐selective Cytosolic Protein Delivery via Reversible Tagging with LAT1 substrate

Effective Therapeutic Drug Delivery by GALA3, an Endosomal Escape Peptide with Reduced Hydrophobicity

Tricyclic cell-penetrating peptides for efficient delivery of functional antibodies into cancer cells

Rational Design of a Polymer with Robust Efficacy for Intracellular Protein and Peptide Delivery

Enhancing Tumor-Specific Intracellular Delivering Efficiency of Cell-Penetrating Peptide by Fusion with a Peptide Targeting to EGFR